{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Andrew", "organization": "", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "news_desk": "Sports", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"print_headline": "Meldonium&#8217;s Benefits Remain a Mystery", "main": "Meldonium&#8217;s Benefits Remain a Mystery"}, "print_page": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Doping (Sports)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Tennis", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Sharapova, Maria", "is_major": "N", "rank": "5", "name": "persons"}], "snippet": "The drug has been sold in Russia and former states of the Soviet Union mainly to treat conditions in which the heart is not getting enough oxygen, but some experts say that the evidence for such claims is scant and that it is not even clear if it improves athletic performance.", "source": "The New York Times", "lead_paragraph": "The drug has been sold in Russia and former states of the Soviet Union mainly to treat conditions in which the heart is not getting enough oxygen, but some experts say that the evidence for such claims is scant and that it is not even clear if it improves athletic performance.", "word_count": "915", "pub_date": "2016-03-10T00:00:00Z", "subsection_name": "Tennis", "blog": [], "type_of_material": "News", "section_name": "Sports", "web_url": "http://www.nytimes.com/2016/03/10/sports/tennis/meldoniums-benefits-remain-a-mystery.html", "_id": "56e0eedd38f0d80718d56426"}